Propel Bio Management, LLC
Position in CLDX — Celldex Therapeutics, Inc.
CIK 1969764
LOS ANGELES, CA
Position in CLDX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,858,490
-$308,376 QoQ
Shares Held
103,695
-21.1% QoQ
Ownership
0.132%
of shares outstanding
% of Portfolio
2.02%
of 13F equity value
Holder Rank
#79
of 252 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 49%
Shared 51%
None 0%
Common Shares in CLDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Propel Bio Management, LLC holds $132,912,353 across 24 Biotechnology names. CLDX ranks #13 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ACHV |
Achieve Life Sciences, Inc.
|
4,034,018 | $26,342,137 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
136,499 | $11,868,588 | |
| 3 | PHAT |
Phathom Pharmaceuticals, Inc.
|
1,050,358 | $11,396,384 | |
| 4 | MIST |
Milestone Pharmaceuticals Inc.
|
7,429,590 | $9,955,650 | |
| 5 | KYTX |
Kyverna Therapeutics, Inc.
|
883,198 | $7,869,294 | |
| 6 | ARTV |
Artiva Biotherapeutics, Inc.
|
696,436 | $6,755,429 | |
| 7 | ABEO |
Abeona Therapeutics Inc.
|
983,070 | $6,075,372 | |
| 8 | PALI |
Palisade Bio, Inc.
|
2,582,388 | $5,397,190 |
All Filings in CLDX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,858,490 | 103,695 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $4,166,866 | 131,364 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $4,190,788 | 154,300 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $4,009,850 | 155,000 | Shares | Defined | 2025-11-12 | |
| No filing history on record for this holder in this stock. | ||||||